Partner with us
Human connective tissue cells under a fluorescence microscope

An international team in RNA biology, aptamers and drug development

Aptadir's founders come from Beth Israel Deaconess Medical Center, the Italian National Research Council, the Cancer Science Institute of Singapore and City of Hope.

Board of directors

Portrait of Giovanni Amabile

Giovanni Amabile, PhD

Founder, CEO and Executive Chairman

Previously CEO of Enthera, where he secured the largest VC-backed Series A for an Italian biotech, and CSO at ADIENNE, where he achieved US marketing approval for thiotepa in 2017.

Portrait of Simone Braggio

Simone Braggio

Board member

Over 30 years in Big Pharma (GSK and affiliates) and CROs (Aptuit, Evotec), in research, strategic partnerships and new business models.

Portrait of Davide Santi

Davide Santi

Board member

Investment career from Amadeus Capital Partners to an Italian healthcare fund, with health economics and market access roles at Amgen and UCB.

Scientific founders

Portrait of Annalisa Di Ruscio

Annalisa Di Ruscio, MD, PhD

Over 15 years in RNA biology and DNA methylation, focused on blood cancers including MDS. Co-founder of SpeaRNA.

Portrait of Vittorio De Franciscis

Vittorio De Franciscis, PhD

Over 35 years of expertise in aptamer technology.

Portrait of Daniel G. Tenen

Daniel G. Tenen, MD

Over 30 years in gene regulation of normal and cancer cells, a leader in leukemia research. Co-founder of Believer Inc. and SpeaRNA.

Portrait of Marcin Kortylewski

Marcin Kortylewski, PhD

Over 20 years in oligonucleotide therapeutics. Co-founder of Duet BioTherapeutics.

Investors

A €40 million seed round in September 2026, the largest biotech seed financing in Italy.

  • 4BIO Capital
  • Extend
  • CDP Venture Capital
  • XGEN Venture
  • CE-Ventures

Partners and investors

For partnering, licensing or investment conversations, write to the team in Milan.

Contact the team

Researchers

Read the peer-reviewed work the platform is built on.

Read the publications